drugset / Trial / NCT06995001
Phase I Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Injection of SHR-2173 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics and immunogenicity of a single dose of SHR-2173 by subcutaneous injection.
Timeline
- Start
- 2024-04-28
- Primary completion
- 2024-11-28
- Completion
- 2024-11-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR-2173 | Unknown | — | Subcutaneous |
Indications
No indication recorded.